FLT3-positive AML: Erste zielgerichtete Therapie
Crossref DOI link: https://doi.org/10.1007/s15004-017-5933-z
Published Online: 2017-12-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
red,
